Cargando…
PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature
BACKGROUND: Recurrent endometrial cancer after definitive therapy is a lethal disease. Recently, immune checkpoint inhibitors (ICI) have improved the management of mismatch repair-deficient (MSI-H) endometrial cancer. Autoimmune side effects are known to occur with ICI. As a result, patients with pr...
Autores principales: | Ramos, Amanda, del Carmen, Marcela, Yeku, Oladapo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479461/ https://www.ncbi.nlm.nih.gov/pubmed/32934857 http://dx.doi.org/10.1155/2020/3428945 |
Ejemplares similares
-
ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020) -
Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022) -
Therapy of ocular complications in ANCA+ associated vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2021) -
The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014) -
Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)